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Background: The right ventricle is a complex structure that is challenging to quantify by two-dimensional (2D)
echocardiography. Unlike disk summation three-dimensional (3D) echocardiography (3DE), single-beat 3DE
can acquire large volumes at high volume rates in one cardiac cycle, avoiding stitching artifacts or long
breath-holds. The aim of this study was to assess the accuracy and test-retest reproducibility of single-
beat 3DE for quantifying right ventricular (RV) volumes in adult populations of acquired RV pressure or volume
overload, namely, pulmonary hypertension (PH) and carcinoid heart disease, respectively. Three-dimensional
and 2D echocardiographic indices were also compared for identifying RV dysfunction in PH.Methods: A prospective cross-sectional study was performed in 100 individuals who underwent 2D echocardi-
ography, 3DE, and cardiac magnetic resonance imaging: 49 patients with PH, 20 with carcinoid heart disease,
11with metastatic carcinoid tumorswithout cardiac involvement, and 20 healthy volunteers. Two operators per-
formed test-retest acquisition and postprocessing for inter- and intraobserver reproducibility in 20 subjects.Results:: RV single-beat 3DE was attainable in 96% of cases, with mean volume rates of 32 to 45 volumes/sec.
Bland-Altman analysis of all subjects (presented asmean bias6 95% limits of agreement) revealed good agree-
ment for end-diastolic volume (2.36 27.4mL) and end-systolic volume (5.26 19.0 mL) measured by 3DE and
cardiac magnetic resonance imaging, with a tendency to underestimate stroke volume (7.5 6 23.6 mL) and
ejection fraction (4.66 13.8%) by 3DE. Subgroup analysis demonstrated a greater bias for volumetric under-
estimation, particularly in healthy volunteers (end-diastolic volume, 11.9 6 18.0 mL; stroke volume,
11.2 6 20.2 mL). Receiver operating characteristic curve analysis showed that 3DE-derived ejection fraction
was significantly superior to 2D echocardiographic parameters for identifying RV dysfunction in PH (sensitivity,
94%; specificity, 88%; area under the curve, 0.95; P = .031). There was significant interobserver test-retest bias
for RV volume underestimation (end-diastolic volume, 12.5 6 28.1 mL; stroke volume, 10.6 6 23.2 mL).Conclusions: Single-beat 3DE is feasible and clinically applicable for volumetric quantification in acquired RV
pressure or volume overload. It has improved limits of agreement compared with previous disk summation 3D
echocardiographic studies and has incremental value over standard 2D echocardiographicmeasures for iden-
tifying RV dysfunction. Despite the ability to obtain and postprocess a full-volume 3D echocardiographic RV
data set, the quality of the raw data did influence the accuracy of the data obtained. The technique performs
better with dilated rather than nondilated RV cavities, with a learning curve that might affect the test-retest
reproducibility for serial RV studies. (J Am Soc Echocardiogr 2015;28:363-74.)
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Abbreviations
CMRI = Cardiac magnetic
resonance imaging
COV = Coefficient of variation
EDV = End-diastolic volume
EF = Ejection fraction
ESV = End-systolic volume
ICC = Intraclass correlation
coefficient
PH = Pulmonary hypertension
ROC = Receiver operating
characteristic
RV = Right ventricular
RVOT = Right ventricular
outflow tract
SV = Stroke volume
TAPSE = Tricuspid annular
plane systolic excursion
3D = Three-dimensional
3DE = Three-dimensional
echocardiography
2D = Two-dimensional
2DE = Two-dimensional
echocardiography
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March 2015Quantification of right ventricular
(RV) size and function is prog-
nostic in congenital and acquired
heart disease.1-4 The most
convenient imaging modality for
assessing the right ventricle is
two-dimensional (2D) echocardi-
ography (2DE). However, this
is limited by the crescentic RV
chamber shape and complex ge-
ometry, with inflow and outflow
portions in different planes.5,6
Thus, cardiac magnetic resonance
imaging (CMRI) has become the
gold-standard imaging modality
for RV quantification.7
Unfortunately,CMRI is expensive,
time consuming, and of limited
availability compared with echo-
cardiography.
One possibility to overcome
the limitations of 2DE is three-
dimensional (3D) echocardiog-
raphy (3DE), compared against
CMRI in a range of congenital
and acquired diseases for RV
volumetric quantification.8
Three-dimensional echocar-
diography traditionally uses the
disk summation method to
reconstruct the right ventricle af-
ter sequential slice acquisition
over consecutive electrocardio-graphically gated heartbeats.9 This technique, however, is limited by
breath holding throughout successive cardiac cycles, stitching artifacts
during acquisition, and difficulties identifying inlet and outflow re-
gions in the basal slices during postprocessing.10
More recently, ultrasound transducer technology allows the real-
time acquisition of a 90  90 data set in a single cardiac cycle.11
We therefore compared RV volumetric quantification by single-beat
full-volume 3DE against CMRI in homogenous patient populations
of acquired RV pressure and volume overload, namely, pulmonary
hypertension (PH) and carcinoid heart disease, respectively. We also
sought to determine the potential incremental value of 3DE versus
2DE in PH and to evaluate the test-retest reproducibility of 3DE for
both the acquisition and postprocessing components.METHODS
Study Population
We performed a prospective cross-sectional study that enrolled 100
participants in sinus rhythm with no contraindications to magnetic
resonance imaging, all of whom underwent comprehensive 2DE,
single-beat 3DE of the right ventricle, and CMRI within 2 hours of
one another. The participants were divided into four subgroups:
 A group of 49 consecutive patients with PH (diagnosed by right heart cath-
eterization as a mean pulmonary artery pressure >25 mmHg and a pulmo-
nary capillary wedge pressure <15 mm Hg12) who presented for diagnosis
and/or follow-up of PH by clinical evaluation and/or right heart catheteriza-tion as a disease model of RV pressure overload. The etiologies of PH
included idiopathic (n = 9), connective tissue disease associated (n = 32),
and chronic thromboembolic disease (n = 8). Exclusion criteria comprised
clinically significant restrictive or obstructive lung disease identified by pul-
monary function tests, arrhythmia, and known independent left-sided
cardiac disease unrelated to PH.
 A group of 20 consecutive patients undergoing 2DE for diagnosis and/or
follow-up of carcinoid heart disease13 were studied as a disease model of
RV volume overload.
 A control group of 20 healthy volunteers affiliated with our institution who
were age and sex matched to the PH group.
 A control group of 11 age- and sex-matched patients with metastatic neuro-
endocrine tumor whowere screened as negative for carcinoid valvular heart
disease.
All control participants were eligible for study inclusion if they had
no cardiac symptomatology, had no medical histories of cardiac
disease including hypertension, and were not taking any cardiac med-
ications. Normal 2D transthoracic echocardiographic findings were
also required to exclude any occult structural cardiac disease before
study inclusion.
The institutional research ethics committee approved the study,
and informedwritten consent was obtained from all patients and con-
trol subjects.2DE
All patients underwent comprehensive 2D andDoppler transthoracic
echocardiography in the left lateral decubitus position using the
Acuson Siemens SC2000 cardiac ultrasound system (Siemens
Healthcare, Erlangen, Germany), with a 4V1c transducer (frequency
bandwidth, 1.25–4.5 MHz). A standard study protocol was followed
in conjunction with American Society of Echocardiography guide-
lines for chamber quantification14,15 and the British Society of
Echocardiography guidelines for PH assessment16 as appropriate.
RV function was assessed using M-mode tricuspid annular plane sys-
tolic excursion (TAPSE); RV fractional area change, calculated as
[(end-diastolic area)  (end-systolic area)/end-diastolic area]  100;
and mean RV free wall peak systolic strain using syngo Vector
Velocity Imaging (Siemens Medical Solutions USA, Inc, Mountain
View, CA). A three-beat 2D echocardiographic digital clip of an apical
four-chamber view optimized for RV visualization was acquired and
exported to Velocity Vector Imaging, and 10 to 15 endocardial points
were plotted in end-systole from the lateral to the medial tricuspid
annulus.17 The adequacy of speckle-tracking was visually checked
and manually adjusted as required.3DE
Image Acquisition. Single-beat full-volume 3D echocardiographic
RV data sets were acquired using the 4Z1c matrix-array transducer
(frequency bandwidth, 1.5–3.5 MHz; maximum depth, 30 cm;
maximum field of view, 90  90). Probe position started from
the apical four-chamber view with the patient in the left lateral decu-
bitus position. Both the patient and transducer positions were subse-
quently modified for optimal simultaneous visualization of the
tricuspid valve, cardiac apex, infundibulum, and RV outflow tract
(RVOT) as assessed by the real-time 2D four-chamber, basal sagittal,
and coronal views, and by inclusion of the RV chamber in the pyrami-
dal data set. In our experience, a more lateral apical windowwith pos-
terior tilt of the probe tail was beneficial to visualize the infundibulum
and RVOT in the coronal window. Image depth and sector width
were adjusted for maximal visualization of the right ventricle at the
Figure 1 Example of the stepwise process of RV reconstruction by 3DE. (A) The cavity area is optimized in the three orthogonal views,
and landmarks are identified (mitral valve indicated by the blue asterisk, tricuspid valve indicated by the red asterisk). Note the RVOT
seen in the coronal view (indicated by the purple asterisk). (B)Having traced endocardial borders in three orthogonal views, the semi-
automated border tracking results are displayed for inspection. Note how the purple guideline (indicated by the purple asterisk) bi-
sects the tricuspid valve and RVOT in the short-axis views. This corresponds to the coronal RV reconstruction (highlighted), with
clearly delineated RV inflow and outflow portions. A4C, Apical four-chamber.
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were acquired during a breath-hold to ensure optimal image quality,
which was subjectively graded on a five-point scale ranging from zero
(very poor) to four (perfect).18 A score of two or less was attributed if
ultrasound dropout was evident in greater than half of the RVOT
border.
Postprocessing. Full-volume 3D echocardiographic RV data sets
were imported into the on-cart RV Analysis application. Manual
adjustment of the RV data set was initially required to ensure thecorrect orientation of four-chamber, sagittal, and coronal slices; maxi-
mize the RV cavity area and identify themost apical RV view on visual
assessment of the four-chamber window; and allow the identification
of cardiac landmarks. This process was performed in a stepwise
approach by rotation and angulation of the four-chamber window,
with manipulation of this plane causing the simultaneous adjustment
of the other two (sagittal and coronal) orthogonal planes (Figure 1A).
Both atrioventricular valves followed by the left ventricular apex were
identified as anatomic landmarks. When the apex of a dilated right
ventricle overrode that of the left ventricle, the most apical cardiac
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diastolic and end-systolic frames were assigned by visual identification
of the largest and smallest RV four-chamber areas, respectively.
Endocardial RV borders were traced at end-diastole and
end-systole in four-chamber, basal sagittal, and coronal views. The
software algorithm obliges the operator to intersect the endocardial
border tracing in sequential views with crosshair reference markers
that are positioned in response to endocardial border traces from a
preceding view. Therefore, correction of a previous slice tracing was
undertaken when a crosshair position suggested a prior tracing error.
Trabeculae were included in the blood pool volume. To assist with
RVOT delineation in the basal sagittal view, the insertion point of
the RV myocardium at the interventricular septum was routinely
included in the endocardial tracing.
At the final stage, the algorithm presents the results of semiauto-
mated contour tracking for the four-chamber, coronal and basal,
middle and apical short-axis views. Misalignment of endocardial con-
tours prompted identification of the region of suboptimal tracking
followed by manual correction of the original tracing. Automated
volumetric reconstruction was accepted only once the semiauto-
mated endocardial border tracking was visually satisfactory and repre-
sented meaningful RV shapes in all views (Figure 1B), as optimization
of this final reconstruction stage significantly affects the results gener-
ated.19 The algorithm from which the final RV volume is generated
has been previously described.20,21
Test-Retest Reproducibility of 3DE. Reproducibility was stud-
ied in 20 randomly selected subjects (14 with PH, one with carcinoid
heart disease, and five healthy volunteers) for both the 3D echocar-
diographic acquisition and postprocessing stages by two independent
sonographers (D.S.K. and A.E.G.), as described previously.22 The two
sonographers had equal experience with 2DE but differing levels of
experience with 3D echocardiographic RV full-volume acquisition
(10 and 3 months, respectively). Sonographer 1 (D.S.K.) obtained a
3D echocardiographic RV data set, after which sonographer 2
(A.E.G.) independently obtained a 3D echocardiographic RV data
set. Then, sonographer 1 acquired a second separate 3D echocardio-
graphic RV data set. The sonographers, who were blinded to each
other’s results, performed postprocessing of their own 3D echocar-
diographic RV data sets. Data sets for intraobserver test-retest repro-
ducibility were postprocessed separately at time intervals of >2
weeks.Cardiac MRI
Image Acquisition. All cardiac magnetic resonance images were
acquired using a 1.5-T magnetic resonance scanner (Avanto;
Siemens Healthcare) using a 12-element phased-array coil for signal
reception and the body coil for signal transmission. A vector electro-
cardiographic systemwas used for cardiac gating. Ventricular volumes
and great vessel flow were measured in all patients. Volumetric RV
data were obtained using either retrospectively gated balanced
steady-state free precession (n = 19) cine imaging of contiguous
short-axis slices23 or real-time radial k-t sensitivity encoding imaging
(n = 81) of contiguous transaxial slices24 depending on the pathology
under investigation and the patient’s ability to hold his or her breath.
Real-time radial k-t sensitivity imaging allows the collection of high
spatiotemporal resolution real-time images during free breathing
and is part of the standard clinical CMRI work flow at our institution
in the pediatric PH population.25 Transaxial RV slices were preferred
for the PH cohort and their respective control population because ofthe relative preservation of longitudinal versus radial RV function that
is manifest in this condition.26 Blood flow data were acquired in the
ascending aorta, in the right and left branch pulmonary arteries, and
at the level of the atrioventricular valves using a velocity-encoded pro-
spectively triggered spiral phase-contrast magnetic resonance flow
sequence.27 This provided an internal check for the RV volumetric
data.
Postprocessing. All image postprocessing was performed using
‘‘in-house’’ plug-ins for the open-source OsiriX Digital Imaging and
Communications in Medicine software.24,28,29 Endocardial RV
borders were traced manually at end-diastole and end-systole, the
time points of which were identified by the largest and smallest RV
cavity areas, respectively. The inclusion of RV trabeculae was the
same as that performed by 3D echocardiographic postprocessing.
Ventricular stroke volume (SV) was the difference between end-
diastolic volume (EDV) and end-systolic volume (ESV), and ejection
fraction (EF) was calculated as (SV/EDV) 100. Phase-contrast mag-
netic resonance flow data were segmented using a semiautomatic
vessel edge detection algorithm with manual operator correction.28
The CMRI data sets for the patients who underwent 3D echocardio-
graphic test-retest reproducibility scans were also tested for interob-
server (D.S.K. and M.A.Q.) and intraobserver postprocessing
reproducibility.Statistical Analysis
Statistical analysis was performed using SPSS version 21.0 (IBM
Corporation, Armonk, NY) and Prism 6.0b for Mac (GraphPad
Software, Inc, La Jolla, CA). Normally distributed continuous data
were expressed as mean6 SD. Systematic differences between mea-
surements were evaluated with Student paired t tests (two tailed),
with Pearson correlation coefficients used to assess the relationship
between 3DE- and CMRI-derived RV volumes and EF. Differences
between the four participant subgroups were analyzed using one-
way analysis of variance, with the Tukey post hoc tests identifying
which specific means differed. P values < .05 were considered statis-
tically significant. Image scoring data were nonparametrically distrib-
uted, represented by medians with 25th and 75th percentiles. Rank
sum tests were used for comparisons of image scoring data, with
theMann-WhitneyU test and the Kruskal-Wallis test used for compar-
isons of two and three independent groups, respectively.
Intermodality, interobserver, and intraobserver agreement was
studied using the Bland-Altman method,30 whereby the mean differ-
ence was presented as the bias and 95% limits of agreement around
the bias expressed as themean difference6 1.96 SDs. Differences be-
tween test-retest measurements were analyzed by one-way repeated
measures analysis of variance, with the Bonferroni post hoc test iden-
tifying which specific means differed. The Greenhouse-Geisser
correction was used if the assumption of sphericity had been violated.
Test-retest variability was expressed using intraclass correlation coeffi-
cients (ICC), relative differences, and coefficients of variation (COVs).
The ICC was quantified by the two-way random-effects model with
absolute agreement. An ICC > 0.85 was considered excellent.
Relative differences were calculated by taking the absolute difference
between two observations divided by the mean of the repeated ob-
servations and expressed as a percentage. COVs were calculated as
the standard deviation of the difference between two acquisitions
divided by their mean value and expressed as a percentage.31 A
COV # 10% was considered excellent.
Table 1 Clinical characteristics of study populations
Variable
PH
(n = 46)
Carcinoid heart
disease (n = 19)
Healthy
volunteers
(n = 20)
Carcinoid (no
valvulopathy) (n = 11) P*
Age (y) 56 6 13 63 6 8 50 6 12 59 6 10
Women 35 (76%) 7 (37%) 15 (75%) 7 (64%)
Height (cm) 164 6 9 171 6 10 169 6 8 168 6 10 .035
Weight (kg) 69 6 17 72 6 18 72 6 12 77 6 20 .54
Body surface area (m2) 1.8 6 0.2 1.8 6 0.3 1.8 6 0.2 1.9 6 0.3 .37
Heart rate (beats/min) 74 6 14 67 6 13 68 6 9 69 6 12 .19
Mean PASP on RHC (mm Hg) 44 6 16
Pulmonary vasodilators
Endothelin antagonist 21 (46%)
PDE-5 antagonist 31 (67%)
Prostanoid infusion 2 (4%)
Oral prostanoid 1 (2%)
Prostaglandin receptor agonist 1 (2%)
Carcinoid heart disease: affected valves TV = 19 (100%), PV = 13 (68%), MV = 3 (16%), AV = 3 (16%)
EDV (mL/m2) 87 6 26 100 6 35 64 6 14 52 6 8 <.0001
ESV (mL/m2) 52 6 25 33 6 15 22 6 7 16 6 5 <.0001
EF (%) 43 6 14 68 6 7 65 6 7 71 6 7 <.0001
3D echocardiographic temporal
resolution (volumes/sec)
34 6 5 32 6 7 40 6 5 45 6 6 <.0001
AV, Aortic valve; ESV, end-systolic volume;MV, mitral valve; PASP, pulmonary artery systolic pressure; PDE-5, phosphodiesterase-5; PV, pulmo-
nary valve; RHC, right heart catheterization; TV, tricuspid valve.
Data are expressed as mean 6 SD or as number (percentage).
*One-way analysis between groups.
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2D and 3D echocardiographic parameters to identify CMRI-
derived RV EFs of <50% in patients with PH and healthy volun-
teers.32 Patients with carcinoid disease were excluded from this
analysis to avoid the confounding effects of severe valvular regurgita-
tion on ventricular function. The area under the ROC curve for an
echocardiographic parameter is presented together with the optimal
cutoff threshold for detecting CMRI-derived RV EF < 50%, defined
as the value of the parameter that corresponded to the highest sum
of sensitivity and specificity. The Delong method was used to
compare the areas under the curve between ROC curves33
(Analyse-it Software, Ltd, Leeds, United Kingdom).RESULTS
Population Characteristics and 3DE Technical Data
Of 100 individuals who were recruited, four had unobtainable RV
echocardiographic windows. The clinical characteristics and 3D echo-
cardiographic technical data of the final cohort of 96 subjects are
presented in Table 1. Patients with PH had significantly larger and
impaired right ventricles than controls, whereas the right ventricles
of patients with carcinoid heart disease were also significantly dilated
but with preserved EFs. The dilated right ventricles of the patient
groups resulted in a significantly lower mean volume rate comparedwith controls because of the greater 3D sector angles (P < .001), but
the median image quality score was significantly higher among
patients (3.00; interquartile range, 2.00–3.00) than controls (2.00 in-
terquartile range, 1.00–3.00) (P < .001). The image quality among
three successive, equally populated subgroups of patients significantly
improved with increasing experience with 3DE (Figure 2; P = .031).
There was a trend, albeit not statistically significant, for greater differ-
ences in SV between modalities with worse subjective image scores
(Figure 3; P< .13 for percentage intermodality difference in SV for im-
age score groups 1 and 2 combined vs groups 3 and 4 combined).Volumetric Analysis by 3DE versus CMRI
Correlation coefficients showed good to excellent correlations be-
tween modalities for RV metrics in patient groups and moderate to
good correlations for control subjects (Table 2). RV volumes and
EFs by 3DE showed differences with CMRI in both patient groups,
with a bias for underestimating SVand EF but with overall acceptable
limits of agreement (Figure 4). By contrast, 3DE underestimated EDV
for control subjects (Table 3), with a consequent negative bias for
quantifying SV in this group (Figure 5).RV Quantification by 3DE and 2DE versus CMRI
Three-dimensional echocardiographic EF was the most superior
echocardiographic parameter for identifying CMRI-derived RV EF
Figure 3 Box-and-whisker plots of differences in stroke volume
betweenmodalities (expressedasapercentageof theCMRI refer-
ence value) for image scoring groups 1 to 4. There was a trend,
albeit not statistically significant, for the intermodality difference
to increasewith reductions in subjective image score.Median per-
centage intermodality differences in stroke volumeby image score
group were as follows: group 1, 22% (interquartile range [IQR],
1% to 26%); group 2, 11% (IQR, 2% to 23%); group 3, 9%
(IQR, 3% to 16%); group 4, 2% (IQR, 6% to 19%).
Table 2 RV volumes and EFs by single-beat full-volume 3DE
versus CMRI
Group Measurement 3DE CMRI P*
PH EDV (mL) 158 6 53 154 6 52 .043
ESV (mL) 100 6 44 92 6 47 <.0001
SV (mL) 58 6 18 63 6 17 .011
EF (%) 39 6 11 43 6 14 .00029
Carcinoid heart
disease
EDV (mL) 182 6 69 185 6 71 .21
ESV (mL) 67 6 28 62 6 3 .01
SV (mL) 115 6 42 124 6 45 .014
EF (%) 64 6 5 68 6 7 .001
Healthy
volunteers
EDV (mL) 105 6 26 117 6 27 <.0001
ESV (mL) 41 6 12 41 6 14 .80
SV (mL) 65 6 16 76 6 18 <.0001
EF (%) 61 6 5 65 6 7 .014
Carcinoid (no
valvulopathy)
EDV (mL) 88 6 21 98 6 27 .05
ESV (mL) 32 6 13 30 6 14 .24
SV (mL) 56 6 10 68 6 14 .009
EF (%) 64 6 7 71 6 7 .004
ESV, End-systolic volume.
Data are expressed as mean 6 SD.
*Paired Student t tests.
Figure 2 Box-and-whisker plots of subjective image quality
scores among three successive subgroups of patients (group
1 acquired in the earliest phase of the study, group 3 in the latest
phase of the study). Image quality significantly improved with
increasing experience with 3DE (P = .031).
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change of 39% (sensitivity, 85%) was the best conventional 2D echo-
cardiographic measure, superior to both peak systolic strain and
TAPSE (P = .0443). TAPSE was the weakest marker to predict
CMRI-derived RV EF < 50%, with sensitivity of 56% at a cutoff
threshold of 19 mm.Test-Retest Intraobserver and Interobserver
Reproducibility
Limits of agreement were acceptable for intra- and interobserver 3D
echocardiographic studies, with good to excellent ICCs (Table 4).
However, there was a significant interobserver bias for underestimat-
ing RV EDV (P= .001; Table 5) that resulted in underestimation of SV
(P = .002) and EF (P = .033), with accompanying large interobserver
COVs and relative differences. Moreover, despite no significant
differences between intraobserver EDV and ESV, the differences
translated into statistically significant test-retest differences for SV
(P = .032) and EF (P = .005). The interobserver and intraobserver
reproducibility for RV volumes and EF by CMRI showed no signifi-
cant bias and superior limits of agreement compared with 3DE.DISCUSSION
This study demonstrates the feasibility of single-beat full-volume 3DE
for RV quantification in, to our knowledge, the largest homogenous
acquired RV pressure- and volume-overloaded patient populations.
Single-beat 3DE is an agreeable technique compared with CMRI,
albeit with significant differences especially in subjects with nondi-
lated right ventricles. Furthermore, 3D echocardiographic parameters
are of incremental benefit for RV functional quantification compared
with traditional 2DE measures.
Accurate quantitation of RV size and function is important in many
congenital and acquired cardiac diseases and is of particular relevance
in our study populations. RV size and function are of greater prog-
nostic significance in PH than the afterload to which the right heart
is exposed,34,35 with RV EF being the key determinant of outcome
regardless of changes in pulmonary vascular resistance afforded by
pulmonary vasodilator therapy.36 Similarly, right heart dilatation is
independently associated with poor outcomes in patients with
advanced carcinoid heart disease.37 However, the right ventricle re-
sponds differently to pressure- and volume-overload conditions,
with dilatation occurring in both but with relative preservation of
Figure 4 Bland-Altman analysis of bias (black solid line) and 95% limits of agreement (red dashed line) for 3DE versus CMRI quan-
tification of RV EDV, ESV, SV, and EF in patients with PH and carcinoid heart disease.
Table 3 Bias, limits of agreement, and correlation between single-beat full-volume 3DE and CMRI for RV volumes and EFs
Group Measurements Bias 6 SD Limits of agreement r P*
All subjects EDV (mL) 2.3 6 13.7 29.1 to 24.5 0.97 <.0001
ESV (mL) 5.2 6 9.5 13.4 to 23.9 0.98 <.0001
SV (mL) 7.5 6 11.8 30.6 to 15.7 0.94 <.0001
EF (%) 4.6 6 6.9 18.2 to 9.0 0.91 <.0001
PH EDV (mL) 4.0 6 13.1 21.6 to 29.7 0.97 <.0001
ESV (mL) 8.4 6 10.6 12. 3 to 29.1 0.98 <.0001
SV (mL) 4.3 6 10.8 25.5 to 17.0 0.82 <.0001
EF (%) 4.8 6 8.3 21.1 to 11.5 0.81 <.0001
Carcinoid heart disease EDV (mL) 3.1 6 10.1 22.9 to 16.8 0.99 <.0001
ESV (mL) 5.4 6 8.2 10.6 to 21.4 0.96 <.0001
SV (mL) 8.6 6 13.9 35.9 to 18.6 0.95 <.0001
EF (%) 3.8 6 4.1 11.9 to 4.2 0.82 <.0001
Healthy volunteers EDV (mL) 11.9 6 9.0 29.5 to 5.8 0.94 <.0001
ESV (mL) 0.4 6 6.7 13.6 to 12.9 0.88 <.0001
SV (mL) 11.2 6 10.1 31.0 to 8.7 0.84 <.0001
EF (%) 3.9 6 6.5 16.6 to 8.8 0.51 .021
Carcinoid (no
valvulopathy)
EDV (mL) 10.1 6 15.0 39.6 to 19.4 0.84 .001
ESV (mL) 2.1 6 5.5 8.7 to 12.9 0.92 <.0001
SV (mL) 12.2 6 12.3 36.3 to 11.9 0.53 .096
EF (%) 6.2 6 5.6 17.1 to 4.7 0.69 .019
ESV, End-systolic volume.
*Pearson correlation coefficient.
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clear is to what extent this preserved EF represents normality of func-
tion in the presence of severe tricuspid regurgitation, a valvular lesion
common to all patients in our carcinoid heart disease cohort.
The incremental benefit of 3DE over 2DE has previously been
shown in congenital heart disease,38 and single-beat 3DE showed
similar added value over 2DE metrics in acquired RV pressure over-load. Although this is due in part to equivalent parameters being as-
sessed by 3DE and CMRI, it is, importantly, also a reflection of the
limitations of conventional 2D echocardiographic measures. TAPSE
had the poorest sensitivity for detecting lowRVEF in PH, with a cutoff
of 19 mm having the highest combined sensitivity and specificity. This
is higher than the recommended threshold of 16mm for detecting RV
dysfunction,14 suggesting that TAPSE would have performed worse
Figure 5 Bland-Altman analysis of bias (black solid line) and 95% limits of agreement (red dashed line) for 3DE versus CMRI quan-
tification of RV EDV, ESV, SV, and EF for subjects in the control populations.
Figure 6 ROC curves for 3DE, fractional area change (FAC), RV
free wall peak systolic strain by speckle-tracking echocardiog-
raphy, and TAPSE to identify RV dysfunction (defined as RV
EF < 50% on CMRI).
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ventricle in pressure overload can give rise to apparently normal
TAPSE values,39 and TAPSE also does not account for the radial
component of RV function that contributes significantly to RV EF.26
By contrast, fractional area change was the most superior 2D echocar-diographic marker for identifying RV dysfunction in PH, most likely a
reflection of being the only 2D echocardiographic marker that ac-
counts for radial function. These findings are consistent with previous
studies comparing 2D echocardiographic markers of RV function in
PH40 and suggest that 3DE may have an important additive role in
assessing RV function.
RV quantification by echocardiography is advantageous through
being more readily available and less expensive than CMRI. Since
the first use of 3DE for RV volumetric quantification,18 improvements
in matrix-array transducer technology permit the simultaneous visual-
ization of orthogonal 2D RV planes at the time of acquisition. The
technique used in this study allows a pyramidal data set of up to
90  90 to be acquired at higher temporal resolutions than previ-
ously reported for 3DE.41 Acquisition of a full volume in a single
heartbeat avoids stitching artifacts associated with acquiring slices
over serial heartbeats and also confers the advantage of shorter
breath-hold durations. These reasons might explain the narrower
limits of agreement for RV volumetric parameters between single-
beat 3DE and CMRI compared with previous data from adult PH
groups using the disk summation method.41,42
The disadvantages of echocardiography include constraints that
afford inadequate transthoracic windows, including body habitus,
hyperinflated lungs, and chest deformities. Acquisition and postpro-
cessing was feasible in 96% of subjects, consistent with previously re-
ported studies using the technique.43,44 However, patients with
significant lung disease were excluded to ensure that PH was the
predominant disease process in the RV pressure-overload group,
and this may in turn have biased the echogenicity of the study popu-
lation. Although all postprocessed 3D echocardiographic data sets
had a reconstructed RV polygon that tracked throughout the cardiac
cycle, 45% of studies were judged by subjective image scoring to have
some endocardial dropout of the outflow portion of the right
ventricle. This was reflected by a trend toward increasing differences
Table 4 Interobserver and intraobserver reproducibility for RV volumes and EF by 3DE and CMRI
Variable EDV (mL) ESV (mL) SV (mL) EF (%)
3DE intraobserver
ICC 0.992 0.974 0.96 0.906
COV (%) 3.0 6.6 8.0 6.9
RD (%) 4.3 9.4 11.3 9.8
Bias 0.2 4.6 4.7 3.6
LOA 16.2 to 15.8 12.8 to 22.0 19.0 to 9.7 12.2 to 5.0
SD 8.2 8.9 7.3 4.4
CMRI intraobserver
Bias 2.6 2.4 0.1 0.7
LOA 15.4 to 10.2 11.3 to 6.5 11.8 to 11.6 5.9 to 7.2
SD 6.5 4.6 6.0 3.4
3DE interobserver
ICC 0.955 0.965 0.867 0.827
COV (%) 7.7 8.0 16.6 9.4
RD (%) 10.3 11.4 23.5 13.3
Bias 12.5 2.0 10.6 4.0
LOA 40.0 to 15.1 24.0 to 20.1 33.2 to 12.1 16.2 to 8.3
SD 14.1 11.3 11.6 6.3
CMRI interobserver
Bias 1.9 2.80 1.1 0.9
LOA 18.2 to 14.4 13.1 to 7.5 9.3 to 11.5 4.1 to 5.8
SD 8.3 5.2 5.3 2.5
ESV, End-systolic volume; LOA, limits of agreement; RD, relative difference.
Table 5 Interobserver and intraobserver test-retest RV metrics by 3DE
Sonographer 1 Sonographer 2
Variable First (S1.1) Second (S1.2) P* S1.1 vs S1.2 Acquisition P* vs S1.1 P* vs S1.2
EDV (mL) 145 6 63 145 6 62 NS 133 6 59 .003 .003
ESV (mL) 78 6 44 83 6 42 NS 76 6 39 NS NS
SV (mL) 67 6 31 63 6 29 .032 57 6 27 .002 .046
EF (%) 48 6 13 44 6 12 .005 44 6 11 .033 NS
ESV, End-systolic volume.
Data are expressed as mean 6 SD.
*One-way repeated-measures analysis of variance with Bonferroni post hoc test.
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dian difference of $11% when the RVOT was incompletely visual-
ized. This is a consistent problem with 3DE that has been well
documented previously and is due to the anterior position of the right
ventricle in the thorax. Postprocessing software extrapolates the
endocardial borders during semiautomated border tracking,45 and
hence although it is possible to analyze data sets with incomplete
RVOT visualization, the accuracy of reconstructions will most likely
deteriorate with progressive dropout in the outflow tract.
When comparing studies of RV quantification by 3DE, the homo-
geneity of the study population must be taken into account. Our pop-
ulations of acquired RV disease were favorable for the 3D
echocardiographic postprocessing software algorithm, because it isset up for an adult-shaped right ventricle rather than a congenital
heart.46 This may be a reason why our limits of agreement were nar-
rower than reported in congenital heart disease.45 No substantial bias
was observed in either the PH or carcinoid heart disease group, but
subgroup analysis showed that EDVs, and consequently SVs, were
underestimated in controls. This is despite the higher temporal reso-
lution of images in this group and is likely a result of low spatial reso-
lution with single-beat 3DE. Lower spatial resolution confers less
ability to resolve myocardium and trabeculae, thus directing the oper-
ator to trace the endocardium further inside the RV cavity and hence
underestimate volumes. This is supported by previous data showing
greater variability and negative bias for 3DE to quantify RV volumes
in nondilated right hearts.47 Conversely, RVendocardial delineation is
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both magnetic resonance imaging and 3DE41,47 and is reflected by
the higher image quality scores observed with our disease cohorts.
The progressive increase in 3D echocardiographic image quality
over the study duration reflects a significant learning curve with the
technique, as also described in previous studies.38 This is important
clinically, as follow-up studies will vary depending on operator expe-
rience for both acquisition and postprocessing. Few studies so far have
addressed 3D echocardiographic test-retest reproducibility for both
the acquisition and postprocessing stages.22,41 Our interobserver
test-retest study demonstrated a second operator bias for EDV under-
estimation, conferring lower SV and EF measurements. This was a
systematic error likely reflecting relative operator inexperience with
the technique. The susceptibility of 3DE to underestimate RV vol-
umes has been well documented,8 and our data suggest that operator
experience is related to this underestimation.
Furthermore, nonsignificant differences in intraobserver EDV and
ESV nevertheless resulted in significant differences in SV and EF
when the errors in the raw volumes were combined. Given that
small changes in endocardial border delineation are known to
confer significant changes in 3DE-derived volumetric parameters in
the left ventricle,48 this is also likely to be a problem with 3DE recon-
struction of the right ventricle too. This is clinically important because
a change of as little as 10 mL in SV by CMRI is clinically significant in
PH,49 but a change of this magnitude may bemasked by 3DE’s repro-
ducibility error and/or the degradation of accuracy found with poorer
quality 3D echocardiographic data sets. For example, the interob-
server measurement of RV SV by 3DE showed a significant bias
with a standard deviation more than double that of CMRI. Our
CMRI reproducibility data show narrow limits of agreement, with
no major bias between observers, consistent with previous reproduc-
ibility studies of RV quantification by transaxial slices50,51 and
sensitive enough to detect small changes in RV indices on serial
studies.Limitations
This study was a single-center study based on acquisitions made by
one sonographer with experience using single-beat 3DE for RV
volumetric quantification. As demonstrated by our test-retest repro-
ducibility, results cannot be applied across operators with variable
experience in 3D echocardiographic RV analysis. Patients with ar-
rhythmias were excluded because of the extra variability introduced
by irregular cardiac cycles when comparing modalities. Single-beat
acquisition is advantageous over traditional disk summation
techniques that are limited by stitching artifacts due to irregular R-R
intervals, and this patient group requires further investigation with
the technique.
We found a bias to underestimate cavity size, particularly in control
subjects, but the study was not designed to compare the accuracy of
the technique in patients with large versus small cavity sizes. This
question should be addressed in a separate prospectively designed
analysis of large versus small right ventricles. The sensitivity and
specificity values for 3DE and 2DE to identify CMRI-derived RVEF
< 50% were calculated by applying the ROC cutoff values to the
same patients used to derive them as described previously,38 hence
representing a ‘‘best case’’ scenario. A more appropriate method
would be to identify cut-off values using ROC analysis in a derivation
group, then prospectively evaluate the cutoff values in a separate test
group in whom outcomes could be verified independently. Thus thediagnostic performance of the cutoff values found in this study needs
to be confirmed independently.
Finally, the study was not designed to provide CMRI test-retest
reproducibility similar to the 3D echocardiographic study design for
acquisition and postprocessing. However, CMRI does not have the
same acquisition window restrictions inherent to transthoracic echo-
cardiography, as contiguous transaxial RV slices of fixed thickness are
acquired from the base of the right heart to the main pulmonary
artery with the patient in the supine position. However, this difference
in technique methodology is a potential source of discrepancy, with
the reference standard of CMRI building volumes frommultiple slices
compared with the full-volume data sets of 3DE.10CONCLUSIONS
Single-beat full-volume 3DE is a feasible technique for quantifying RV
size and function in acquired right heart pressure and volume
overload. The limits of agreement of 3DE are acceptable compared
with CMRI but may not be sensitive enough to detect small yet clin-
ically significant responses to treatment demonstrated by this modal-
ity.49 The test-retest reproducibility of 3DE suggests a significant
learning curve that needs to be considered, and thus results cannot
necessarily be extrapolated to less experienced operators.
Nevertheless, 3DE showed incremental benefit over conventional
2D echocardiographic measures, suggesting an important role in as-
sessing acquired RV pathology. Future work should focus on
improving spatial resolution to optimize RV endocardial delineation,
in particular for adequate visualization of the RVOT in nondilated
right ventricles.REFERENCES
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